Han Joo Cho1, Soo Hyun Lim2, Jaemin Kim2, Jihyun Lee2, Dong Won Lee2, Jong Woo Kim2. 1. Kim's Eye Hospital, Konyang University College of Medicine, 156, 4ga, Yeongdeungpo-dong, Yeongdeungpo-gu, Seoul, South Korea. chojoo@kimeye.com. 2. Kim's Eye Hospital, Konyang University College of Medicine, 156, 4ga, Yeongdeungpo-dong, Yeongdeungpo-gu, Seoul, South Korea.
Abstract
PURPOSE: To analyze the evolution of type 3 neovascularization in eyes with age-related macular degeneration during anti-vascular endothelial growth factor (VEGF) treatment using optical coherence tomography angiography (OCTA) analysis. METHODS: Forty-one treatment-naïve eyes (37 patients) with type 3 neovascularization were retrospectively included in the study. The growth and morphological changes in the type 3 lesions, which were recorded using OCTA, were compared across time. RESULTS: The high-flow signal of the lesion on OCTA was significantly increased at the sub-retinal pigment epithelium (RPE) and the choriocapillaris during anti-VEGF treatment. The detection rate of the flow signal in the sub-RPE increased from 50.0% at baseline and 51.2% at 12 months to 65.9% at 24 months (P = 0.013). The flow signal extending into the choriocapillaris was detected in 0% of the eyes at baseline, 9.8% of the eyes at 12 months, and 17.1% of the eyes at 24 months (P = 0.018). The presence of subretinal drusenoid deposits (SDD) was significantly more frequent in the group with extension into the choriocapillaris (100%) than in the group without (61.8%, P = 0.036). For the four eyes with extension into the choroid, the morphological feature of the lesion on en face OCTA evolved into a tangled vascular network, similar to type 1 neovascularization. CONCLUSION: OCTA analysis revealed that type 3 neovascularization gradually extended downward toward the sub-RPE and choroid during anti-VEGF treatment. The extension of the lesion into the choriocapillaris, suggesting retinal-choroidal anastomosis, was significantly more frequent in eyes with SDD.
PURPOSE: To analyze the evolution of type 3 neovascularization in eyes with age-related macular degeneration during anti-vascular endothelial growth factor (VEGF) treatment using optical coherence tomography angiography (OCTA) analysis. METHODS: Forty-one treatment-naïve eyes (37 patients) with type 3 neovascularization were retrospectively included in the study. The growth and morphological changes in the type 3 lesions, which were recorded using OCTA, were compared across time. RESULTS: The high-flow signal of the lesion on OCTA was significantly increased at the sub-retinal pigment epithelium (RPE) and the choriocapillaris during anti-VEGF treatment. The detection rate of the flow signal in the sub-RPE increased from 50.0% at baseline and 51.2% at 12 months to 65.9% at 24 months (P = 0.013). The flow signal extending into the choriocapillaris was detected in 0% of the eyes at baseline, 9.8% of the eyes at 12 months, and 17.1% of the eyes at 24 months (P = 0.018). The presence of subretinal drusenoid deposits (SDD) was significantly more frequent in the group with extension into the choriocapillaris (100%) than in the group without (61.8%, P = 0.036). For the four eyes with extension into the choroid, the morphological feature of the lesion on en face OCTA evolved into a tangled vascular network, similar to type 1 neovascularization. CONCLUSION:OCTA analysis revealed that type 3 neovascularization gradually extended downward toward the sub-RPE and choroid during anti-VEGF treatment. The extension of the lesion into the choriocapillaris, suggesting retinal-choroidal anastomosis, was significantly more frequent in eyes with SDD.
Authors: Laura Kuehlewein; Kunal K Dansingani; Talisa E de Carlo; Marco A Bonini Filho; Nicholas A Iafe; Tamara L Lenis; K Bailey Freund; Nadia K Waheed; Jay S Duker; SriniVas R Sadda; David Sarraf Journal: Retina Date: 2015-11 Impact factor: 4.256
Authors: Alexandra Miere; Giuseppe Querques; Oudy Semoun; Ala'a El Ameen; Vittorio Capuano; Eric H Souied Journal: Retina Date: 2015-11 Impact factor: 4.256
Authors: David Xu; Juan Pablo Dávila; Mansour Rahimi; Carl B Rebhun; A Yasin Alibhai; Nadia K Waheed; David Sarraf Journal: Am J Ophthalmol Date: 2017-12-18 Impact factor: 5.258
Authors: Aaron Nagiel; David Sarraf; Srinivas R Sadda; Richard F Spaide; Jesse J Jung; Kavita V Bhavsar; Hossein Ameri; Giuseppe Querques; K Bailey Freund Journal: Retina Date: 2015-04 Impact factor: 4.256
Authors: Miaoling Li; Rosa Dolz-Marco; Jeffrey D Messinger; Lan Wang; Richard M Feist; Christopher A Girkin; Sarra Gattoussi; Daniela Ferrara; Christine A Curcio; K Bailey Freund Journal: Ophthalmology Date: 2017-09-28 Impact factor: 12.079